CALA Shares Outstanding History
Below is a table of the CALA shares outstanding history going back to 10/2/2014:

Date CALA Shares Outstanding
10/2/2014794079
10/31/2014896520
3/20/2015897320
4/30/2015897320
7/31/2015905672
10/31/2015906794
3/7/2016920548
5/3/2016947765
8/4/2016974477
11/4/20161.04M
3/10/20171.37M
5/5/20171.76M
8/4/20171.77M
10/31/20171.77M
3/6/20181.79M
5/7/20181.79M
8/2/20181.80M
11/2/20181.91M
3/4/20191.94M
5/3/20191.96M
8/2/20192.69M
12/31/20183.75M
11/8/20192.69M
3/4/20203.23M
5/4/20203.52M
8/6/20203.53M
11/2/20203.53M
3/10/20213.67M
5/3/20213.70M
8/3/20213.71M
11/4/20213.75M
3/25/20223.94M
5/6/20224.86M
8/11/20224.87M

Also see: CALA Market Cap History
CALA YTD Return
CALA Historical Shares Outstanding:
+25.93% CAGR
CALA Historical Shares Outstanding: +25.93% CAGR

Mouse over chart for data details
10/2/2014 ...8/11/2022
Calithera Biosciences is a clinical-stage precision oncology biopharmaceutical company developing targeted therapies to redefine treatment for biomarker-specific patient populations. Co.'s product candidate, CB-280, is an oral inhibitor of arginase, developed for the treatment of cystic fibrosis. Co. has also identified CB-668, an orally administered inhibitor of the immune-suppressive enzyme IL4I1. An additional arginase inhibitor, INCB001158, was discovered by Co. and is being developed by Incyte Corporation for oncology and hematology indications. Co. has developed CB-708, a selective, orally-bioavailable small molecule inhibitor of CD73. We show 34 historical shares outstanding datapoints in our coverage of CALA's shares outstanding history.

Understanding the changing numbers of CALA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CALA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CALA by allowing them to research CALA shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree CALA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Calithera Biosciences (CALA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

CAPR Shares Outstanding History
CARA Shares Outstanding History
CASI Shares Outstanding History
CASM Shares Outstanding History
CATB Shares Outstanding History
CATS Shares Outstanding History
CBAY Shares Outstanding History
CBIO Shares Outstanding History
CBLI Shares Outstanding History
CBM Shares Outstanding History
More Healthcare companies »

 

CALA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.